538P Nadunolimab (CAN04), a first-in-class monoclonal antibody against IL1RAP, in combination with chemotherapy in subjects with pancreatic cancer (PDAC) and non-small cell lung cancer (NSCLC)

Authors :: Richard Greil
Christiane Jungels
Luis Paz-Ares
E. Van Cutsem
Lars Thorsson
L. Østergaard Poulsen
Sebastian Ochsenreither
S. Cicenas
Dirk Arnold
J. Yachnin
M. Zematis
Joëlle Collignon
R.L. Eefsen
I. Garcia Ribas
Ahmad Awada
Per Pfeiffer
Source :: Annals of Oncology. 32:S602-S603
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Chemotherapy
Oncology
medicine.drug_class
business.industry
medicine.medical_treatment
Pancreatic cancer
medicine
Cancer research
non-small cell lung cancer (NSCLC)
Hematology
medicine.disease
Monoclonal antibody
business

Tools